Back to top

Tale of the Tape

Zacks Equity Research

Cynosure, Inc. (CYNO) Looks Good: Stock Adds 6% in Session
February 14, 2014


Trades from $3
Cynosure, Inc. (CYNO - Free Report) was a big mover last session, as the company saw its shares rise nearly 6% on the day. This rally higher can be attributable to solid volume with far more shares changing hands than in a normal session. This broke the recent trend of the company, as the stock is now trading above the volatile price range of $25.87 to $27.53 in the past one-month time frame.

In the last 30 days, while this company did not witness any estimate revisions, the Zacks Consensus Estimate has moved higher suggesting that more solid trading could be ahead for Cynosure. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

Cynosure currently has a Zacks Rank #1 (Strong Buy) while its Earnings ESP is negative.

Some better-ranked stocks in the healthcare industry include Actelion Ltd. (ALIOF - Free Report) , Gentium S.p.A and Cambrex Corporation. (CBM - Free Report) . All these stocks hold a Zacks Rank #1 (Strong Buy).  

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Cynosure, Inc. (CYNO) - free report >>

Actelion Ltd. (ALIOF) - free report >>

Cambrex Corporation (CBM) - free report >>